The Feasibility of Using the PulsePoint to Facilitate Overdose Education and Naloxone Distribution
Running, not enrolling · Not applicable
Conditions studied: Carrying Naloxone/Narcan on Their Person or in Their Vehicle, Being Trained to Respond to an Opioid Overdose
In brief
This study is a feasibility trial to assess whether, in a random sample of 180 agencies where PulsePoint is already active, revised procedures (hereinafter PulsePoint-OD) to facilitate opioid overdose and naloxone distribution (OEND) can successfully recruit first responder agencies and layperson responders. For this study, agency refers to a single implementation site where PulsePoint is active and that is bound by the service area or jurisdiction of the first responder agency collaborating with PulsePoint. The study will test the following hypotheses: H1: more first responder agencies will be successfully recruited by arm 2 than by arm 1. H2: more layperson responders will report engaging with OEND programming in arm 2 than in arms 1 or 3 and in arm 1 than in arm 3 \[only this hypothesis is covered by the IRB, hypothesis 1 is not human subjects research\].
Key facts
- Study ID
- NCT06523985
- Run by
- Indiana University
- People needed
- 5000
- Starts
- 2024-08-07
- Expected to finish
- 2026-10-01
- Last updated by the study team
- 2026-07-29
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Indiana University Bloomington — Bloomington, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.